Histology | Adenocarcinoma (n = 27) | Squamous cell carcinoma (n = 42) |
Age (years) | 63.55 ± 10.8 | 66.2 ± 7.7 |
Gender | 20 male (74.1%) 7 female (25.9%) | 41 male (97.6%) 71 female (2.4%) |
Operation type | Pneumectomy: 3 (11.1%) Lobectomy: 22 (81.5%) Bilobectomy: 2 (7.4%) | Pneumectomy: 10 (23.8%) Lobectomy: 27 (64.3%) Bilobectomy: 5 (11.9%) |
Lymphnodes resected (n) | 17.8 ± 6.8 | 20.9 ± 8.6 |
Pathologic Stage | IA: 3 (11.1%) IB: 13 (48.1%) IIA: 1 (3.7%) IIB: 4 (14.8%) IIIA: 6 (22.2%)
| IA: 3 (7.1%) IB: 12 (28.6%) IIA: 9 (21.4%) IIB: 8 (19.0%) IIIA: 9 (21.4%) IIIB: 1 (2.4%) |
T-Status | T1a: 17 (18.5%) T1b: 6 (22.2%) T2a: 10 (37.0%) T2b: 4 (14.8%) T3: 2 (7.4%)
| T1a: 3 (7.1%) T1b: 7 (16.7%) T2a: 13 (31.0%) T2b: 9 (21.4%) T3: 7 (16.7%) T4: 3 (7.1%) |
N-Status | N0: 17 (63%) N1: 16 (14.8%) N2: 6 (22.2%)
| N0: 27 (64.3%) N1: 9 (21.4%) N2: 5 (11.9%) N3: 1 (2.4%) |
Grading | 1˚ Grade: 1 (3.7%) 2˚ Grade: 17 (63.0%) 3˚ Grade: 9 (33.3%) |
2˚ Grade: 28 (66.7%) 3˚ Grade: 14 (33.3%) |
Mean follow up time (month) | 35 ± 27.9 | 51.5 ± 35.9 |